We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Gastroenterology

Journal Scan / Research · September 07, 2021

Placebo Response Rates in Trials of Licensed Drugs for Irritable Bowel Syndrome

Clinical Gastroenterology and Hepatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Gastroenterology and Hepatology
Placebo Response Rates in Trials of Licensed Drugs for Irritable Bowel Syndrome With Constipation or Diarrhea: Meta-Analysis
Clin. Gastroenterol. Hepatol. 2021 Aug 20;[EPub Ahead of Print], B Barberio, EV Savarino, CJ Black, AC Ford

Further Reading